Christopher Flint Obrien - Net Worth and Insider Trading

Christopher Flint Obrien Net Worth

The estimated net worth of Christopher Flint Obrien is at least $7 Million dollars as of 2025-07-20. Christopher Flint Obrien is the Former Chief Medical Officer of Neurocrine Biosciences Inc and owns about 55,946 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $7 Million. Details can be seen in Christopher Flint Obrien's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Flint Obrien has not made any transactions after 2018-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Christopher Flint Obrien

To

Christopher Flint Obrien Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Flint Obrien owns 1 companies in total, including Neurocrine Biosciences Inc (NBIX) .

Click here to see the complete history of Christopher Flint Obrien’s form 4 insider trades.

Insider Ownership Summary of Christopher Flint Obrien

Ticker Company Transaction Date Type of Owner
NBIX Neurocrine Biosciences Inc 2018-02-05 Sr. VP & Chief Medical Officer

Christopher Flint Obrien Latest Holdings Summary

Christopher Flint Obrien currently owns a total of 1 stock. Christopher Flint Obrien owns 55,946 shares of Neurocrine Biosciences Inc (NBIX) as of February 5, 2018, with a value of $7 Million.

Latest Holdings of Christopher Flint Obrien

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBIX Neurocrine Biosciences Inc 2018-02-05 55,946 132.02 7,385,991

Holding Weightings of Christopher Flint Obrien


Christopher Flint Obrien Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Flint Obrien has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 2,613 shares on February 5, 2018, which brought Christopher Flint Obrien around $217,349.

Insider Trading History of Christopher Flint Obrien

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Flint Obrien Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Flint Obrien Ownership Network

Ownership Network List of Christopher Flint Obrien

No Data

Ownership Network Relation of Christopher Flint Obrien

Insider Network Chart


Christopher Flint Obrien Owned Company Details

What does Neurocrine Biosciences Inc do?

Who are the key executives at Neurocrine Biosciences Inc?

Christopher Flint Obrien is the Sr. VP & Chief Medical Officer of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Regulatory Officer Ingrid Delaet , Chief Scientific Officer Jude Onyia , and Sr VP & Business Development Kevin Charles Gorman .

Neurocrine Biosciences Inc (NBIX) Insider Trades Summary

Over the past 18 months, Christopher Flint Obrien made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 34,005 shares made by Ingrid Delaet , a net sale of 178,724 shares made by Eric Benevich , and a net sale of 54,716 shares made by Matt Abernethy .

In summary, during the past 3 months, insiders sold 120,251 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 120,251 shares. During the past 18 months, 907,472 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 907,472 shares.

Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neurocrine Biosciences Inc Insider Transactions

No Available Data

Christopher Flint Obrien Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Flint Obrien. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher Flint Obrien's mailing address is: San Diego Ca 92130.